Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma.

J Clin Oncol

Edward R. Scheffer Cliff, MBBS, MPH, Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Gemma Reynolds, MChD, MIDI, National Center for Infections in Cancer, Department of Infectious D

Published: April 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.22.02197DOI Listing

Publication Analysis

Top Keywords

acknowledging infection
4
infection risk
4
risk bispecific
4
bispecific antibody
4
antibody trials
4
trials treatment
4
treatment multiple
4
multiple myeloma
4
acknowledging
1
risk
1

Similar Publications

Introduction: There is growing incidence of postpartum stroke globally. We aim to assess the incidence rate, predicting factors and outcome of postpartum stroke in a middle income country. In one year long bidirectional study, patients with acute postpartum stroke developed within six weeks after delivery were cases compared to matched control group without stroke in 1:2 ratio.

View Article and Find Full Text PDF

The pathogenesis of dengue remains complex and incompletely understood. One proposed mechanism involves the virus evading host immune responses through the upregulation and/or secretion of immune-inhibitory molecules. This study investigates the association between plasma levels of soluble human leukocyte antigen G (sHLA-G), a known immunoregulatory molecule, and dengue severity in hospitalized patients.

View Article and Find Full Text PDF

The escalating cancer burden in Sub-Saharan Africa (SSA), with projected doubling of incidence and mortality by 2040, necessitates innovative, cost-effective strategies for prevention, diagnosis, and treatment. While known infectious triggers like HPV, hepatitis viruses, and account for an estimated 28.7% of cancers in SSA, the full scope of microbially-mediated oncogenesis remains underexplored.

View Article and Find Full Text PDF

In September 2023, Sweden experienced its first ever outbreak of African swine fever (ASF). One year later, in September 2024, Sweden was declared free from ASF. One of the first actions taken toward control and eradication was an intensive search for wild boar carcasses.

View Article and Find Full Text PDF

Stingless bee propolis: a comprehensive review of chemical constituents and health efficacy.

Nat Prod Bioprospect

September 2025

Department of Toxicology, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, 13200, Kepala Batas, Pulau Pinang, Malaysia.

Propolis, consisting of plant-derived materials, wax, and bee secretions, is abundant in bioactive constituents like flavonoids, phenolic compounds, and terpenes, which enhance its various biological functions. These encompass antioxidant, anti-inflammatory, antibacterial, anticancer, antidiabetic, and immunomodulatory properties. Propolis has demonstrated effectiveness in the prevention and treatment of multiple illnesses, including cardiovascular disease, atherosclerosis, infections, diabetes, wound healing, and burns.

View Article and Find Full Text PDF